Insulin injection is the most essential and available treatment for T1D; however, many patients show not only poor metabolic control, but also hemoglobin A1C levels that remain above seven as well as further complications such as hypoglycemia, overweight, and dyslipidemia. This evidence concerns the gene INS and type 1 diabetes mellitus.